LNG  
News

Focus on demand and innovate mode
Continuously create value for customers and provide differentiated products and services

Ten medical device manufacturers in Shanghai were informed

  Time of publication:2020-06-11

Prior to the July 10 news from China Financial Network, the Shanghai Food and Drug Administration issued a notice on the flight inspection of medical device manufacturers, and Shanghai Dongshunyu Technology Co., Ltd. confiscated the notices from 10 medical device manufacturers.



The announcement shows that Shanghai Dongtang Fangshunyu Technology Co., Ltd. and Kang Huayao Biotechnology (Shanghai) Co., Ltd. do not meet the relevant provisions of the medical device production quality management standards, which may lead to hidden safety hazards. They should be recalled in accordance with the "Administrative Measures" for the recall of medical devices. Regulations

Shanghai Burton Medical Devices Co., Ltd. is suspected of producing and selling second-class medical devices on site without a license, violating the provisions of the "Regulations for the Supervision and Administration of Medical Devices", investigated by the Pudong New Area Market Supervision Bureau, and complying with the law

Shanghai Baixiang Biotechnology Co., Ltd., Shanghai Yihua, Kenna (Shanghai) Co., Ltd. Stellite Metal does not meet the relevant provisions of the medical device production quality management standards, and the product quality management system has serious defects;

Shanghai Fahrenheit Asia-Pacific Biopharmaceutical Co., Ltd. is closed. Before resuming production, the enterprise should report in writing to the Market Supervision Bureau of Jiading District, and production can be resumed if the requirements are met.

Shanghai Qingsheng Electronic Instrument Co., Ltd. and Shanghai Fudan Zhangjiang Biomedicine Co., Ltd. are in a state of suspension. Before resuming production, the enterprise shall report in writing to the local market supervision bureau, and after verifying that it meets the requirements, it may resume production.

Shanghai Biotechnology Institute Coxim has no original production license. The enterprise applied for cancellation of the "Medical Device Manufacturing Enterprise License" on June 29, 2017.

The Shanghai Food and Drug Administration has requested the relevant market supervision departments to urge enterprises to implement rectification in accordance with the above measures, seriously investigate and deal with illegal acts, and eliminate risks in a timely manner.


Share to: